Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, 91198, France.
Department of Chemistry, Imperial College, Molecular Sciences Research Hub, Wood Lane, London, W12 0BZ, UK.
Nat Commun. 2020 Feb 28;11(1):1132. doi: 10.1038/s41467-020-14847-3.
The promising drug target N-myristoyltransferase (NMT) catalyses an essential protein modification thought to occur exclusively at N-terminal glycines (Gly). Here, we present high-resolution human NMT1 structures co-crystallised with reactive cognate lipid and peptide substrates, revealing high-resolution snapshots of the entire catalytic mechanism from the initial to final reaction states. Structural comparisons, together with biochemical analysis, provide unforeseen details about how NMT1 reaches a catalytically competent conformation in which the reactive groups are brought into close proximity to enable catalysis. We demonstrate that this mechanism further supports efficient and unprecedented myristoylation of an N-terminal lysine side chain, providing evidence that NMT acts both as N-terminal-lysine and glycine myristoyltransferase.
有前景的药物靶点 N-豆蔻酰转移酶(NMT)催化一种被认为仅在 N 端甘氨酸(Gly)上发生的必需蛋白修饰。在这里,我们展示了与人 NMT1 结构共结晶的高分辨率反应性同源脂质和肽底物,揭示了从初始到最终反应状态的整个催化机制的高分辨率快照。结构比较,以及生化分析,提供了关于 NMT1 如何达到催化能力构象的意想不到的细节,在这种构象中,反应基团被拉近以实现催化。我们证明,这种机制进一步支持了 N 端赖氨酸侧链的高效和前所未有的豆蔻酰化,这表明 NMT 既作为 N 端赖氨酸和甘氨酸豆蔻酰转移酶发挥作用。